Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Logan

Showing results (481-490 of 516) with videos related to

Pageof 52
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2021
National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant CyclophosphamideBronwen E Shaw, Antonio Martin Jimenez-Jimenez, Linda J Burns, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2015
Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection CentersBronwen E Shaw, Brent R Logan, Deidre M Kiefer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 30, 2017
Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34<sup>+</sup> Yields Are LessDavid F Stroncek, Bronwen E Shaw, Brent R Logan, et al.
Blood Advances|November 21, 2025
CHARM is Prognostic of Geriatric Morbidity and Toxicity after Allogeneic Transplant for Older Adults: BMT CTN 1704 StudyAndrew S Artz, Brent R Logan, Wael Saber, et al.
NEJM Evidence|February 25, 2025
Haploidentical Bone Marrow Transplantation for Sickle Cell DiseaseAdetola A Kassim, Mark C Walters, Mary Eapen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 2, 2013
Unrelated donor allogeneic transplantation after failure of autologous transplantation for acute myelogenous leukemia: a study from the center for international blood and marrow transplantation researchJames M Foran, Steven Z Pavletic, Brent R Logan, et al.
The Journal of Allergy and Clinical Immunology|August 20, 2022
Aberrant T-cell exhaustion in severe combined immunodeficiency survivors with poor T-cell reconstitution after transplantationRoxane Labrosse, Ines Boufaied, Benoîte Bourdin, et al.
Blood Advances|March 18, 2025
Novel Composite Health Assessment Risk Model for Older Allogeneic Transplant Recipients: BMT-CTN 1704Mohamed L Sorror, Wael Saber, Brent R Logan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2020
Collection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated DonorsJack W Hsu, Bronwen E Shaw, Soyoung Kim, et al.
Blood|January 8, 2025
Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD-mutated AMLMark J Levis, Mehdi Hamadani, Brent R Logan, et al.
Pageof 52

Showing results (481-490 of 516) with videos related to

Sort By:
Pageof 52
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2021
National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant CyclophosphamideBronwen E Shaw, Antonio Martin Jimenez-Jimenez, Linda J Burns, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2015
Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection CentersBronwen E Shaw, Brent R Logan, Deidre M Kiefer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 30, 2017
Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34<sup>+</sup> Yields Are LessDavid F Stroncek, Bronwen E Shaw, Brent R Logan, et al.
Blood Advances|November 21, 2025
CHARM is Prognostic of Geriatric Morbidity and Toxicity after Allogeneic Transplant for Older Adults: BMT CTN 1704 StudyAndrew S Artz, Brent R Logan, Wael Saber, et al.
NEJM Evidence|February 25, 2025
Haploidentical Bone Marrow Transplantation for Sickle Cell DiseaseAdetola A Kassim, Mark C Walters, Mary Eapen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 2, 2013
Unrelated donor allogeneic transplantation after failure of autologous transplantation for acute myelogenous leukemia: a study from the center for international blood and marrow transplantation researchJames M Foran, Steven Z Pavletic, Brent R Logan, et al.
The Journal of Allergy and Clinical Immunology|August 20, 2022
Aberrant T-cell exhaustion in severe combined immunodeficiency survivors with poor T-cell reconstitution after transplantationRoxane Labrosse, Ines Boufaied, Benoîte Bourdin, et al.
Blood Advances|March 18, 2025
Novel Composite Health Assessment Risk Model for Older Allogeneic Transplant Recipients: BMT-CTN 1704Mohamed L Sorror, Wael Saber, Brent R Logan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2020
Collection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated DonorsJack W Hsu, Bronwen E Shaw, Soyoung Kim, et al.
Blood|January 8, 2025
Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD-mutated AMLMark J Levis, Mehdi Hamadani, Brent R Logan, et al.
Pageof 52